Fox Chase Cancer Center, Sylvester Comprehensive Cancer Center, and Pfizer’s Institute of Translational Equitable Medicine formed a collaboration to launch a cancer genomics study to characterize novel genetic, molecular, and social determinants of cancer across populations of African ancestry.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe